Ingrezza (valbenazine) is used to treat tardive dyskinesia (TD) and chorea associated with Huntington's disease. Ingrezza uses, side effects, doses, and more.

Learn about uses, side effects, and more for Ingrezza (valbenazine), a prescription capsule that treats certain movement disorders, such as tardive dyskinesia.

Ingrezza (valbenazine) is a brand-name prescription drug used to treat tardive dyskinesia in adults. Learn about side effects, warnings, dosage, and more.

Find patient medical information for Ingrezza (valbenazine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings

Learn how always once-daily INGREZZA® (valbenazine) capsules can be used to treat tardive dyskinesia (TD). See PI, including Boxed Warning, and Med Guide.

VMAT2 inhibitors, including INGREZZA and INGREZZA SPRINKLE, can increase the risk of depression and suicidal thoughts and behavior in patients with Huntington’s disease. Anyone …

Ingrezza (valbenazine) is a VMAT2 inhibitor that's used to treat tardive dyskinesia (TD) in adults. It can also treat chorea (random muscle movements) in adults with Huntington's disease. …

Ingrezza (valbenazine) is a brand-name drug prescribed for specific movement disorders. Learn about side effects, uses, dosage, versus Austedo, and more.

COMMON BRAND NAME (S): INGREZZA What should I tell my care team before I take this medication? They need to know if you have any of these conditions: Heart disease History of …

Side Effects Overview of Ingrezza Ingrezza (valbenazine) is a medication for the treatment of tardive dyskinesia. It was approved in April 2017 by the U.S. Food and Drug Administration …